Doncho V. Zhelev
0000-0001-8800-7044
Publication & Citation Trends
Publications
0 total
Chimeric antigen receptor-T cells are effective against CEACAM5 expressing non-small cell lung cancer cells resistant to antibody-drug conjugates OA
Cited by 18
Semantic Scholar
GPC2 antibody–drug conjugate reprograms the neuroblastoma immune milieu to enhance macrophage-driven therapies OA
Cited by 25
Semantic Scholar
Antibody–Drug Conjugate Efficacy in Neuroblastoma: Role of Payload, Resistance Mechanisms, Target Density, and Antibody Internalization OA
Cited by 20
Semantic Scholar
Effective killing of cells expressing CD276 (B7-H3) by a bispecific T cell engager based on a new fully human antibody OA
Cited by 9
Semantic Scholar
GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity. OA
Cited by 141
Semantic Scholar
A GPC2 antibody-drug conjugate is efficacious against neuroblastoma and small-cell lung cancer via binding a conformational epitope OA
Cited by 31
Semantic Scholar
Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection OA
Cited by 84
Semantic Scholar
Abstract A08: Development of FGFR4-specific chimeric antibody receptor (CAR) T cell and bispecific T cell engager (BiTE) for rhabdomyosarcoma (RMS) immunotherapy
Cited by 3
Semantic Scholar
Research Topics
Lipid Membrane Structure and Behavior
(16)
Microbial Inactivation Methods
(13)
Microfluidic and Bio-sensing Technologies
(12)
Cell Adhesion Molecules Research
(11)
Cellular Mechanics and Interactions
(10)
Affiliations
University of British Columbia
DEVCOM Army Research Laboratory
University of Pittsburgh
Duke University
Durham University